US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...
This method has shown promise in managing multiple AK lesions effectively while minimizing discomfort associated with traditional PDT[5]. Actinic Keratosis (AK): A pre-cancerous skin condition ...
Actinic keratosis is a common skin condition that ... particularly focusing on PDT. Completion of patient enrollment in a significant Phase 3 clinical trial for Ameluz® signifies progress in ...
Biofrontera announced the enrollment of the final patient in its Phase 3 clinical trial evaluating Ameluz for the treatment of mild to moderate ...
Denmark: A recent randomized clinical trial, VAXAK, has highlighted the potential benefits of human papillomavirus (HPV) ...
It's a variant of actinic keratosis (AK), another precancerous skin condition that can happen on other parts of the body. The ...
Standard human papillomavirus (HPV) vaccination reduced actinic keratosis (AK) burden in immunocompetent individuals with multiple lesions, with effects observed in both the total number of ...